Generated by AI
Nautilus Biotechnology, Inc. is a life sciences company focused on proteomics, the large-scale study of proteins and their functions. Nautilus Biotechnology develops a platform technology designed to quantify and analyze the human proteome with high resolution, combining instrumentation, consumables, software, and analysis tools into an integrated workflow. Its current products and systems support single-molecule protein analysis and multi-cycle proteome mapping, serving research-oriented markets in biotechnology, pharmaceuticals, and academic science. The company’s platform is intended to help scientists examine protein complexity more deeply, supporting applications in biomedical research, disease biology, and drug discovery. Headquartered in Seattle, Washington, with research and development operations in San Carlos, California, Nautilus Biotechnology operates as a development-stage company in the life sciences tools segment.
Website2701 Eastlake Avenue East
Seattle, WA, 98102
United States
The latest articles about NAUT.
Summary of Nov 16's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Summary of Nov 16's posts. Generated by AI.
Investors talking about NAUT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.